Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice
Experimental and Clinical Endocrinology & Diabetes · 01.08.2024 · 132 (08) · 420-430
DOI: 10.1055/a-2298-4593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2024. Verfasst von Fanglin Qin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Renmin Hospital of Wuhan University, 99 Zhang Zhidong Road, Wuchang District, Wuhan, Hubei Province 430060, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycosides, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Cognitive dysfunction is an important comorbidity of diabetes. Insulin resistance may play a critical role in diabetes-related cognitive impairment. Echinacoside (ECH), a natural phenylethanoid glycoside, is the active component of anti-diabetes prescriptions in traditional Chinese medicine. Its effect on modulating insulin resistance has been confirmed but modulating neurodegenerative disease remains unclear.
Methods
Db/db mice, a spontaneous type 2 diabetes mode, were intragastrically administered ECH by 300 mg/kg or an equivalent volume of saline. Weight, blood glucose, and insulin resistance index were measured. Morris water maze test was performed to observe the compound effects on cognition. Hippocampal lesions were observed by histochemical analysis.
Results
In db/db mice, ECH alleviated diabetes symptoms, memory loss, and hippocampal neuronal damage. Next, the expression of CD44 and phosphorylated tau was upregulated in diabetic mice. In addition, the insulin receptor substrate-1/phosphatidylinositol 3-kinase /protein kinase B signaling pathway was dysregulated in diabetic mice. All these dysregulations could be reversed by ECH.
Discussion
This study provides theoretical support and experimental evidence for the future application of ECH in diabetic cognition dysfunction treatment, promoting the development of traditional medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Renmin Hospital of Wuhan University, 99 Zhang Zhidong Road, Wuchang District, Wuhan, Hubei Province 430060, China.
Förderung
- Hubei Natural Science Foundation of China
Zitieren
APA
Qin, F., Yan, Y., Yang, N., & Hao, Y. (2024). Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice. Experimental and Clinical Endocrinology & Diabetes, 132(08), 420-430. https://doi.org/10.1055/a-2298-4593
Vancouver
Qin F, Yan Y, Yang N, Hao Y. Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice. Experimental and Clinical Endocrinology & Diabetes. 2024;132(08):420-430. doi:10.1055/a-2298-4593
BibTeX
@article{Qin2024,
author = {Qin, Fanglin and Yan, Yiming and Yang, Ningxi and Hao, Yarong},
title = {Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {08},
pages = {420--430},
doi = {10.1055/a-2298-4593}
}
EUVIMED